Laird Norton Trust Company, LLC Inmune Bio, Inc. Transaction History
Laird Norton Trust Company, LLC
- $727 Million
- Q2 2025
A detailed history of Laird Norton Trust Company, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 37,000 shares of INMB stock, worth $65,860. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,000
Previous 36,600
1.09%
Holding current value
$65,860
Previous $285,000
70.18%
% of portfolio
0.01%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding INMB
# of Institutions
94Shares Held
6.28MCall Options Held
1.51MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.45 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.06 Million45.87% of portfolio
-
Ubs Group Ag449KShares$799,6130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$694,0770.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $31.9M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...